Long-term results of carbidopa/levodopa enteral suspension across the day in advanced Parkinson’s disease: Post-hoc analyses from a large 54-week trial

INTRODUCTION: Carbidopa/levodopa enteral suspension (CLES) previously demonstrated reduction in total daily OFF from baseline by over 4 hours in advanced Parkinson’s disease patients across 54 weeks. Evidence on CLES’s long-term effectiveness on patterns of motor-symptom control throughout the day r...

Descripción completa

Detalles Bibliográficos
Autores principales: Pahwa, Rajesh, Aldred, Jason, Merola, Aristide, Gupta, Niodita, Terasawa, Emi, Garcia-Horton, Viviana, Steffen, David R., Kandukuri, Prasanna L., Bao, Yanjun, Ladhani, Omar, Yan, Connie H., Chaudhari, Vivek, Isaacson, Stuart H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803946/
https://www.ncbi.nlm.nih.gov/pubmed/36594071
http://dx.doi.org/10.1016/j.prdoa.2022.100181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803946/
https://www.ncbi.nlm.nih.gov/pubmed/36594071
http://dx.doi.org/10.1016/j.prdoa.2022.100181

Ejemplares similares